HTX 0.00% 0.1¢ healthlinx limited

My understanding is that OvPlex is more accurate than the...

  1. 50 Posts.
    My understanding is that OvPlex is more accurate than the current standard being used, CA125. It wont misclassiffy as many patients. In other words, it is more reliable than CA125 - & especially in early stage ovarian cancer (OC). Also, I think that OvPlex can classify healthy vs benign OC vs malignant OC, where as CA125 is limited to healthy vs OC - but less accurately. The former would definetely be a better clinical tool, in my opinion.

    I somehow dont think that it'll be a good thing hearing that one may not have OC, when they actually may have & conversely diagnosing a person with OC, when they havent. It's a tool used for better diagnosis & hence, a proper evaluation going forward.

    I will contact HTX to confirm accordingly.
 
watchlist Created with Sketch. Add HTX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.